Page last updated: 2024-09-04

pyropheophorbide a and oleic acid

pyropheophorbide a has been researched along with oleic acid in 2 studies

Compound Research Comparison

Studies
(pyropheophorbide a)
Trials
(pyropheophorbide a)
Recent Studies (post-2010)
(pyropheophorbide a)
Studies
(oleic acid)
Trials
(oleic acid)
Recent Studies (post-2010) (oleic acid)
1030638,7682483,051

Protein Interaction Comparison

ProteinTaxonomypyropheophorbide a (IC50)oleic acid (IC50)
Tyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)6.2

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
He, Z; Ji, B; Kan, Q; Li, Z; Luo, C; Sun, B; Sun, J; Wang, K; Wang, M; Wang, Y; Wei, L; Yang, B; Zhang, D; Zhang, H; Zhang, X1
Chen, Q; Chen, Y; He, Z; Luo, C; Sun, B; Sun, J; Wang, C; Yu, H; Zhang, X; Zhao, H1

Other Studies

2 other study(ies) available for pyropheophorbide a and oleic acid

ArticleYear
Light-activatable dual-source ROS-responsive prodrug nanoplatform for synergistic chemo-photodynamic therapy.
    Biomaterials science, 2018, Nov-01, Volume: 6, Issue:11

    Topics: Animals; Cell Survival; Chlorophyll; Drug Carriers; Drug Liberation; Drug Synergism; Intracellular Space; Light; Male; Mice; Nanostructures; Oleic Acid; Photochemotherapy; Photosensitizing Agents; Prodrugs; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Taxoids; Tissue Distribution

2018
Photodynamic PEG-coated ROS-sensitive prodrug nanoassemblies for core-shell synergistic chemo-photodynamic therapy.
    Acta biomaterialia, 2019, 07-01, Volume: 92

    Topics: Animals; Cell Death; Cell Line, Tumor; Chlorophyll; Drug Liberation; Endocytosis; Humans; Light; Mice, Nude; Nanoparticles; Oleic Acid; Paclitaxel; Photochemotherapy; Polyethylene Glycols; Prodrugs; Reactive Oxygen Species; Tissue Distribution; Xenograft Model Antitumor Assays

2019